About the Company
We do not have any company description for TriSalus Life Sciences, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 12, 2025 TriSalus Life Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $-0.22. Operator: Good afternoon, and ...
TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.21 per share a year ago.
TriSalus Life Sciences Inc (TLSI) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ...
TriSalus Life Sciences Inc (TLSI) reports a 52% sales increase and successful product launches, while navigating increased expenses and strategic investments.
Earnings To Watch: TriSalus Life Sciences Inc (TLSI) Reports Q2 2025 Result
TriSalus Life Sciences Inc (NASDAQ:TLSI) is set to release its Q2 2025 earnings on Aug 12, 2025. The consensus estimate for Q2 2025 revenue is $10.69 million, and the earnings are expected to come in ...
TriSalus Life Sciences Inc TLSI - Morningstar
TriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting Business Wire Mar 21, 2024 5:00am ...
TriSalus Life Sciences, Inc. (TLSI) Q4 2023 Earnings Call Transcript
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2023 Earnings Conference Call April 1, 2024 9:00 AM ETCompany ParticipantsJim Young - Senior Vice President, ...
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue ...
TriSalus Life Sciences, Inc., which belongs to the Zacks Medical - Products industry, posted revenues of $9.17 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 1.04%.
TLSI - TriSalus Life Sciences Inc Price vs Fair Value - Morningstar
Find out if TriSalus Life Sciences Inc (TLSI:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of the ...
TriSalus Life Sciences Inc. (TLSI) Stock Price Today - WSJ
View the latest TriSalus Life Sciences Inc. (TLSI) stock price, news, historical charts, analyst ratings and financial information from WSJ.
TriSalus Life Sciences, Inc. (TLSI) Soars 6.6%: Is Further ... - Nasdaq
TriSalus Life Sciences, Inc. (TLSI) shares soared 6.6% in the last trading session to close at $5.49. The move was backed by solid volume with far more shares changing hands than in a normal session.
TriSalus Life Sciences, Inc. (TLSI) Q4 2024 Earnings Call Transcript
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) Q4 2024 Earnings Conference Call March 27, 2025 8:00 AM ET Company Participants Jeremy Feffer - Managing Director, LifeSci Advisors Mary Szela ...
Similar Companies
Loading the latest forecasts...